Latham Advises on Growth Financing for Centinel Spine to Finance Treatments for Cervical and Spinal Diseases

Centinel Spine®, LLC (the Company), a leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), has announced that it has entered into a senior secured loan agreement with credit funds managed by SLR Capital Partners, LLC (SLR) to provide the Company with US$60 million of capital at close and the ability to draw down up to US$10 million in additional capital. The proceeds from the initial funding of the term loan will be used to retire the Company's existing credit facility, pay related fees and expenses, and provide additional working capital.

Latham & Watkins LLP represented SLR Capital Partners with a deal team led by partners Haim Zaltzman and Dan Van Fleet, with associates Axel Magnusson and Ian Drazen. Advice was also provided on tax matters by partner Eric Cho; and on general finance matters by counsel Emily Leong Yu.